$26.03
+0.91 (+3.62%)
Open$25.04
Previous Close$25.12
Day High$26.67
Day Low$25.04
52W High$26.26
52W Low$10.96
Volume—
Avg Volume959.3K
Market Cap1.35B
P/E Ratio—
EPS$-0.15
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+91.4% upside
Current
$26.03
$26.03
Target
$49.81
$49.81
$29.15
$49.81 avg
$64.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 392.17M | 371.09M | 329.37M |
| Net Income | -22,047,387 | -18,776,162 | -60,795,749 |
| Profit Margin | -5.6% | -5.3% | -18.5% |
| EBITDA | -29,095,729 | -26,155,320 | -79,903,104 |
| Free Cash Flow | — | — | -60,969,564 |
| Rev Growth | +5.7% | +5.7% | -9.3% |
| Debt/Equity | — | — | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |